News + Filings Transactions
|
Nagendran Sukumar
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 9.6k | $6.37 | $61.5k | | 06/06/2023 |
| 05/16/2023 | Taysha Gene Therapies, Inc. | | Purchase | Common Stock | 5k | $0.68 | $3.4k | | 05/16/2023 |
| 12/30/2022 | Taysha Gene Therapies, Inc. | | Grant | Stock Option (right to buy) | 790.1k | $2.26 | $1.8M | | 12/30/2022 |
| 12/13/2022 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 9.6k | $6.47 | $62.4k | | 12/13/2022 |
| 06/17/2022 | Taysha Gene Therapies, Inc. | | Grant | Stock Option (right to buy) | 15.5k | $2.81 | $43.6k | | 06/17/2022 |
| 06/07/2022 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 51k | $0.63 | $31.9k | | 06/07/2022 |
| 02/02/2022 | Taysha Gene Therapies, Inc. | | Purchase | Common Stock | 10k | $8.01 | $80.1k | | 02/02/2022 |
| 06/17/2021 | Taysha Gene Therapies, Inc. | | Grant | Stock Option (right to buy) | 15.5k | $25.04 | $388.1k | | 06/17/2021 |
| 06/16/2021 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 30k | $3.94 | $118.2k | | 06/16/2021 |
| 09/28/2020 | Taysha Gene Therapies, Inc. | | Conversion | Common Stock | 19.2k | $0.00 | $0 | | 09/28/2020 |
| 09/28/2020 | Taysha Gene Therapies, Inc. | | Conversion | Series B Preferred Stock | 17.6k | $0.00 | $0 | | 09/28/2020 |
| 09/23/2020 | Taysha Gene Therapies, Inc. | | Grant | Stock Option (right to buy) | 31k | $20.00 | $620k | | 09/23/2020 |
| 06/16/2020 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 10k | $3.03 | $30.3k | | 06/16/2020 |
| 06/16/2020 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 30k | $3.03 | $90.9k | | 06/16/2020 |
| 07/25/2019 | Solid Biosciences Inc. | SLDB | Grant | Common Stock | 32.3k | $4.65 | $150k | | 07/25/2019 |
| 06/13/2019 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 10k | $5.26 | $52.6k | | 06/13/2019 |
| 12/13/2018 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 17.2k | $23.58 | $406.5k | | 12/13/2018 |
| 09/12/2018 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 2.8k | $50.65 | $139.8k | | 09/12/2018 |
| 03/13/2018 | AveXis, Inc. | AVXS | Grant | Common Stock | 3.8k | $0.00 | $0 | | 03/13/2018 |
| 03/13/2018 | AveXis, Inc. | AVXS | Grant | Employee Stock Option (Right to Buy) | 15k | $133.80 | $2M | | 03/13/2018 |
| 03/01/2018 | AveXis, Inc. | AVXS | Exercise | Common Stock | 1.8k | $18.47 | $32.9k | | 03/01/2018 |
| 03/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 74 | $121.51 | $9k | | 03/01/2018 |
| 03/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 120 | $123.16 | $14.8k | | 03/01/2018 |
| 03/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 175 | $124.29 | $21.8k | | 03/01/2018 |
| 03/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 449 | $125.72 | $56.4k | | 03/01/2018 |
| 03/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 504 | $126.95 | $64k | | 03/01/2018 |
| 03/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 408 | $127.99 | $52.2k | | 03/01/2018 |
| 03/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 50 | $128.91 | $6.4k | | 03/01/2018 |
| 02/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 1k | $117.12 | $117.2k | | 02/01/2018 |
| 02/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 501 | $118.01 | $59.1k | | 02/01/2018 |
| 02/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 3 | $118.96 | $356.9 | | 02/01/2018 |
| 02/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 258 | $120.79 | $31.2k | | 02/01/2018 |
| 02/01/2018 | AveXis, Inc. | AVXS | Sale | Common Stock | 17 | $122.83 | $2.1k | | 02/01/2018 |
| 02/01/2018 | AveXis, Inc. | AVXS | Exercise | Employee Stock Option (Right to Buy) | 1.8k | $18.47 | $32.9k | | 02/01/2018 |
| 02/01/2018 | AveXis, Inc. | AVXS | Exercise | Employee Stock Option (Right to Buy) | 1.8k | $18.47 | $32.9k | | 03/01/2018 |
|
|